Allergy/Asthma/Immunology

Top Story

FDA approves Fasenra for eosinophilic asthma maintenance therapy

November 15, 2017

The FDA has approved Fasenra for additional maintenance treatment of severe eosinophilic asthma in patients 12 years and older, according to the manufacturer release.

The approval of Fasenra (benralizumab, AstraZeneca) stems from the results of a program of studies, which included phase 3 exacerbation trials and a phase 3 oral corticosteroid-sparing trial. The respiratory biologic, which diminishes eosinophils within 24 hours, has not been approved for the treatment of other eosinophilic conditions, or the relief of acute bronchospasms or status asthmaticus.

In the JournalsPerspective

High dose peanut patch shows promise for peanut sensitivity

November 14, 2017
Patients with peanut sensitivity who wore a 250-µg epicutaneous immunotherapy-based peanut patch had a significant treatment response compared to patients wearing…
Meeting News

Novel hereditary angioedema therapy reduces attacks, treatment-related costs

November 10, 2017
BOSTON — A C1-esterase inhibitor (human) delivered subcutaneously for the treatment of long-term prophylaxis associated with hereditary angioedema decreased…
In the Journals

Recommendations inconsistent in pediatric asthma guidelines

November 8, 2017
Although national and international guidelines for the treatment of pediatric bronchiolitis have many similarities, less agreement is found in guidelines for the
More Headlines »
CME

Best of Obesity Forum® 2017

This activity is supported by an educational grant from Novo Nordisk, Inc.

The incidence of obesity has increased dramatically over the past 20 years and is considered to be an epidemic in the…
More »
GI Bookshelf

Chapter 6: Nutrients To Nourish The Organisms: Prebiotics And Fiber

From Probiotics: A Clinical Guide
More »
Resource Centers
American Heart Association Scientific Sessions

American Heart Association Scientific Sessions

Video
Meeting News

VIDEO: Vicki Lawrence discusses her chronic idiopathic urticaria

March 8, 2017
More »